List of Triptodur Kit drug patents

Triptodur Kit is owned by Arbor Pharms Llc.

Triptodur Kit contains Triptorelin Pamoate.

Triptodur Kit has a total of 1 drug patent out of which 0 drug patents have expired.

Triptodur Kit was authorised for market use on 29 June, 2017.

Triptodur Kit is available in for suspension, extended release;intramuscular dosage forms.

The generics of Triptodur Kit are possible to be released after 30 June, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10166181 ARBOR PHARMS LLC Slow release pharmaceutical composition made of microgranules
Jun, 2029

(6 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Jun 29, 2024

Drugs and Companies using TRIPTORELIN PAMOATE ingredient

Market Authorisation Date: 29 June, 2017

Treatment: NA

Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in